Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Priority to KR7600666ApriorityCriticalpatent/KR790001232B1/en
Application grantedgrantedCritical
Publication of KR790001232B1publicationCriticalpatent/KR790001232B1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Thiazole And Isothizaole Compounds
(AREA)
Abstract
The title compd. [I; R = H, halogen as F, Cl, Br, I, (C1-C3)alkyl, or (C1-C3) alkoxy as methoxy, ethoxy, R1 = (C1-C3) alkyl as methyl, ethyl, n-propyl, isopropyl, or phenyl , useful as immuno-suppressants, were prepd. by reaction of N-(6-hydroxybenzothiazol-2-yl)-N'-phenylurea with anhydrous products of propionic acid, isopropionic acid, butyric acid, isobutyric acid, or benzoic acid in the presence of pyridine.
KR7600666A1976-03-191976-03-19Process for preparingn-(6-acyloxy benzothiazol-2-yl)-('-phenyl (or substituted phenyl) ureas
KR790001232B1
(en)
METHOD FOR SYNTHESIZING 2-(4-METOXYPHENYLPROPIONYL)AMINO-6-n-PROPYLAMINO-4,5,6,7-TETRAHYDROBENZOTHIASOL IN FORM OF RACEMATE OR (-)-ENANTIOMER OR ITS ACID ADDITIVE SALT